Panbela Therapeutics Stock Price, News & Analysis
PBLA
OTC Link
Company Description
Welcome to the overview page for Panbela Therapeutics (PBLA), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
Latest News
SEC Filings
No SEC filings available for Panbela Therapeutics.
Financial Highlights
-$25,263,000
Net Income (TTM)
-$25,249,000
Operating Cash Flow
0.25
-$25,647,000
—
Revenue (TTM)
Upcoming Events
Short Interest History
Last 12 Months
Loading short interest data...
Days to Cover History
Last 12 Months
Loading days to cover data...
Frequently Asked Questions
What is the current stock price of Panbela Therapeutics (PBLA)?
The current stock price of Panbela Therapeutics (PBLA) is $0.0065 as of January 27, 2026.
What is the market cap of Panbela Therapeutics (PBLA)?
The market cap of Panbela Therapeutics (PBLA) is approximately 242.7K. Learn more about what market capitalization means .
What is the net income of Panbela Therapeutics (PBLA)?
The trailing twelve months (TTM) net income of Panbela Therapeutics (PBLA) is -$25,263,000.
What is the operating cash flow of Panbela Therapeutics (PBLA)?
The operating cash flow of Panbela Therapeutics (PBLA) is -$25,249,000. Learn about cash flow.
What is the current ratio of Panbela Therapeutics (PBLA)?
The current ratio of Panbela Therapeutics (PBLA) is 0.25, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.
What is the operating income of Panbela Therapeutics (PBLA)?
The operating income of Panbela Therapeutics (PBLA) is -$25,647,000. Learn about operating income.